The 2012 London Regenerative Medicine Event -16 February 2012

regenerativemedicineandtissueengineering

Continued improvement in the nation’s health depends upon the development of affordable and effective medicines and new therapeutic treatments. The last 20 years has seen the growth of a global healthcare industry based on human proteins produced in transformed mammalian cell lines, with a current market value of £30 billion/year. There is now an...

Read more »

Cell culture technology: Recent advances,future prospects – 9th March 2012

Cell culture technology: Recent advances,future prospects – 9th March 2012

"In the last 4 decades mammalian cell culture has matured from being merely a research tool into being one of the foundations of the biopharmaceutical industry, and its use...

Read more »

2nd Annual Regulatory Cells in Autoimmunity event: Analysing and moderating function – 29 March 2012

2nd Annual Regulatory Cells in Autoimmunity event: Analysing and moderating function – 29 March 2012

After our first very successful meeting we are pleased to announce our 2nd Annual Regulatory Cells in Autoimmunity event: Analysing and moderating function which will take...

Read more »

The 2012 Histopathology Event: Advances in research and techniques – 30th March 2012

immunohistochemistry

This is the 9th Annual event (originally called Improving Immunohistochemistry) and is the flagship meeting for Euroscicon. Held in the centre of London this meeting draws together international...

Read more »

Strategies for commercial success of biosimilars – 19 April 2012

pills (1)

Whilst biopharmaceuticals remain a major component of the global therapeutics market, the ever expanding portfolio of products losing patent protection and with increasing healthcare costs remaining a poignant issue,...

Read more »

Innovations in Renewable Energies – 27th April 2012

renew

The UK government has announced significant investment in renewable energy research throughout the UK. UK researchers have been involved in the development of many new processes and...

Read more »

Biomarker discovery: Driving technologies – 17th May 2012

biomark

Biomarkers identifying biological and physiological entities associated with disease are taking an increasingly important place at the tables of drug discovery and personalised medicine. Their discovery in biosamples requires...

Read more »

Taking the heat out of chaperokine function – 23 May 2012

heat

The meeting will explore the diverse functions of heat shock proteins over and above their action as chaperones and stress indicators. The role of HSPs in health and disease...

Read more »

Multidisciplinary integrated approaches to understand evasion of host immune responses by pathogens – 20 June 2012

Pathogen

Infectious disease are still a major cause of morbidity an mortality worldwide. Successful treatment and prevention are still hampered by insufficient understanding of the subtle interactions that govern the...

Read more »

Forum for Disaster Victim Identification-29 June 2012

Forum for Disaster Victim Identification-29 June 2012

The procedure of identifying victims of disasters either major (such as terrorist attacks or earthquakes) or smaller (such as aeroplane crashes) cannot rely on visual recognition alone. Comparison...

Read more »

Sign up for our Newsletter

Follow Us!

testimonials

iPhone App

RSS Euroscicon News

This site is regularly updated with information regarding the one day Life Science events within the UK run by Euroscicon

Euroscicon